Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series

American Journal on Addictions

Volumn 24, Issue 1, 2015, Pages 10-14

  Suzuki, Joji ^a,b   Devido, Jeffrey ^c,d   Kalra, Inder ^e   Mittal, Leena ^a,b   Shah, Sejal ^a,b   Zinser, Jennifer ^a   Weiss, Roger D ^b,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EINSTEIN MEDICAL CENTER   (United States)

^f MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; OPIATE; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; CASE STUDY; CHRONIC PAIN; CLINICAL ARTICLE; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MALE; OPIATE ADDICTION; OUTPATIENT; PATIENT REFERRAL; PERSONAL EXPERIENCE; PRESCRIPTION; RATING SCALE; RETROSPECTIVE STUDY; TREATMENT DURATION; WITHDRAWAL SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ATTITUDE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BUPRENORPHINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84961295345     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12161     Document Type: Article

References (20)

1. Laine C, Hauck WW, Gourevitch MN, et al. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA. 2001; 285: 2355-2362.
2. Haber PS, Demirkol A, Lange K, et al. Management of injecting drug users admitted to hospital. Lancet. 2009; 374: 1284-1293.
3. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. [Internet]. Substance Abuse and Mental Health Services Administration; 2012 [cited 2013 Jul 23]. Available from: http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.htm.
4. Parran TV Jr, Adelman CL, Jasinski DR,. A buprenorphine stabilization and rapid-taper protocol for the detoxification of opioid-dependent patients. Am J Addict. 1994; 3: 306-313.
5. Umbricht A, Hoover DR, Tucker MJ, et al. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend. 2003; 69: 263-272.
6. Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial. JAMA Intern Med [Internet]. 2014 Jun 30 [cited 2014 Jul 10]. Available from: http://dx.doi.org/10.1001/jamainternmed.2014.2556.
7. Center for Substance Abuse Treatment,. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, Maryland: Substance Abuse and Mental Health Services Administration; 2004.
8. Shanahan CW, Beers D, Alford DP, et al. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med. 2010; 25: 803-808.
9. Pecoraro A, Horton T, Ewen E, et al. Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment. Addict Sci Clin Pract. 2012; 7: 20.
10. Aszalos R, McDuff DR, Weintraub E, et al. Engaging hospitalized heroin-dependent patients into substance abuse treatment. J Subst Abuse Treat. 1999; 17: 149-158.
11. Caplehorn JR, Dalton MS, Cluff MC, et al. Retention in methadone maintenance and heroin addicts' risk of death. Addict Abingdon Engl. 1994; 89: 203-209.
12. Ling W, Amass L, Shoptaw S, et al. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addict Abingdon Engl. 2005; 100: 1090-1100.
13. McCance-Katz EF, Sullivan LE, Nallani S,. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: A review. Am J Addict. 2010; 19: 4-16.
14. Meader N,. A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: A mixed treatment comparison meta-analysis. Drug Alcohol Depend. 2010; 108: 110-114.
15. Jalili M, Fathi M, Moradi-Lakeh M, Zehtabchi S,. Sublingual buprenorphine in acute pain management: A double-blind randomized clinical trial. Ann Emerg Med. 2012; 59: 276-280.
16. Payandemehr P, Jalili M, Mostafazadeh Davani, et al. Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial. Int J Emerg Med. 2014; 7: 1.
17. Suzuki J, Matthews M, Brick D, et al. Implementation of a collaborative care management program with buprenorphine in primary care: A comparison between opioid-dependent patients and patients with chronic pain using opioids non-medically. J Opioid Manag. 2014; 10: 159-168.
18. Caldiero RM, Parran TV Jr, Adelman CL, et al. Inpatient initiation of buprenorphine maintenance vs. detoxification: Can retention of opioid-dependent patients in outpatient counseling be improved. Am J Addict. 2006; 15: 1-7.
19. Dunn KE, Sigmon SC, Strain EC, et al. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug Alcohol Depend. 2011; 119: 1-9.
20. Weiss RD, Potter JS, Griffin ML, et al. Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain. J Subst Abuse Treat. 2014; 47: 140-145.